EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Cost-effectiveness of the CNIC-Polypill versus separate monocomponents in cardiovascular secondary prevention in Spain

A González-Domínguez, A Durán, Á Hidalgo-Vega, V Barrios

Revista Clínica Española (English Edition) · 2023

DOI: 10.1016/j.rceng.2023.06.007 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Revista Clínica Española (English Edition), 2023. Verfasst von A González-Domínguez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Fundación Weber, Madrid, Spain. Electronic address: almudena.gonzalez@weber.org.es. Hauptthemen laut MEDLINE: Aspirin, Cardiovascular Diseases. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION AND OBJECTIVES: Despite advances in treatment, cardiovascular disease is the second leading cause of death in Spain. The objective of this study was to determine the cost-effectiveness of the CNIC-Polypill strategy (acetylsalicylic acid 100 mg, atorvastatin 20/40 mg, ramipril 2.5/5/10 mg) compared with the same separate monocomponents for the secondary prevention of recurrent cardiovascular events in adults in Spain. MATERIALS AND METHODS: A Markov cost-utility model was adapted considering 4 health states (stable, subsequent major adverse cardiovascular event, subsequent ischemic stroke and death) and the SMART risk equation over a lifetime horizon from the perspective of the Spanish National Healthcare System. The CNIC-Polypill strategy was compared with monocomponents in a hypothetical cohort of 1000 secondary prevention patients. Effectiveness, epidemiological, cost and utilities data were obtained from the NEPTUNO study, official databases and literature. Outcomes were costs (in 2021 euros) per life-year (LY) and quality-adjusted LY (QALY) gained. A 3% discount rate was applied. Deterministic one-way and probabilistic sensitivity analyses evaluated the robustness of the model. RESULTS: The CNIC-Polypill strategy in secondary prevention results in more LY (13.22) and QALY (11.64) gains at a lower cost than monocomponents. The CNIC-Polypill is dominant and saves є280.68 per patient compared with monocomponents. The probabilistic sensitivity analysis shows that 82.4% of the simulations are below the threshold of є25,000 per QALY gained. CONCLUSIONS: The CNIC-Polypill strategy in secondary cardiovascular prevention is cost-effective compared with the same separate monocomponents, resulting in a cost-saving strategy to the Spanish National Healthcare System.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AspirinCardiovascular DiseasesAdultHumansCost-Benefit AnalysisSecondary PreventionSpainAtorvastatinRamiprilQuality-Adjusted Life Years

Stichwörter der Autor:innen

Cardiovascular diseasesCost-effectivenessCoste-efectividadEnfermedades cardiovascularesPolipíldoraPolypillPrevención secundariaSecondary prevention

Substanzen

AtorvastatinAspirinRamipril

Autor:innen und Institutionen

  • Fundación Weber, Madrid, Spain. Electronic address: almudena.gonzalez@weber.org.es.
  • Fundación Weber, Madrid, Spain.
  • President Fundación Weber, Madrid, Spain; Professor at Universidad de Castilla-La Mancha, Toledo, España.
  • Servicio de Cardiología, Hospital Universitario Ramón y Cajal, Madrid, Spain; Servicio de Medicina, Universidad de Alcalá, Alcalá de Henares, Madrid, Spain.

Zitieren

APA

González-Domínguez, A., Durán, A., Hidalgo-Vega, Á., & Barrios, V. (2023). Cost-effectiveness of the CNIC-Polypill versus separate monocomponents in cardiovascular secondary prevention in Spain. Revista Clínica Española (English Edition). https://doi.org/10.1016/j.rceng.2023.06.007

Vancouver

González-Domínguez A, Durán A, Hidalgo-Vega Á, Barrios V. Cost-effectiveness of the CNIC-Polypill versus separate monocomponents in cardiovascular secondary prevention in Spain. Revista Clínica Española (English Edition). 2023. doi:10.1016/j.rceng.2023.06.007

BibTeX
@article{GonzlezDomnguez2023,
  author = {González-Domínguez, A and Durán, A and Hidalgo-Vega, Á and Barrios, V},
  title = {Cost-effectiveness of the CNIC-Polypill versus separate monocomponents in cardiovascular secondary prevention in Spain},
  journal = {Revista Clínica Española (English Edition)},
  year = {2023},
  doi = {10.1016/j.rceng.2023.06.007}
}
Kostenlos starten →